Natera, Inc. Contract with Customer, Liability increased by 28.3% to $53.86M in Q1 2026 compared to the prior quarter.
An increase indicates higher deferred revenue and future service obligations, while a decrease suggests revenue is being recognized faster than new prepayments are received.
This represents the obligation to transfer services to a customer for which the entity has received consideration or for...
Similar to deferred revenue or contract liabilities reported by other asset management and financial services companies.
other_contract_with_customer_liability| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $36.59M | $37.26M | $41.97M | $53.86M |
| QoQ Change | — | +1.8% | +12.6% | +28.3% |
| YoY Change | — | — | +14.7% | +44.5% |
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Royalty | — | — | — | — | — | — | $1.40M | $500.00K |
| Oncology Assay Interpretation Services | $200.00K | $700.00K | $1.20M | $3.20M | $18.90M | $3.00M | — | — |
| Total | — | — | — | — | — | — | $36.59M | $41.97M |
Oncology Assay Interpretation Services was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.